Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 4, 2010
Reporting Period: First Quarter and three months ended March 31, 2010
The Company issued an Investor News release on May 4, 2010, announcing its first-quarter 2010 earnings results. The filing serves to furnish this news release to the SEC as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results, including GAAP and non-GAAP measures, are contained within the attached Investor News (Exhibit 99.1).
Non-GAAP Measures Discussed:
- EBITDA: Defined as operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: Used to supplement GAAP results.
The filing notes that reconciliations between these non-GAAP measures and the most comparable GAAP measures are included in the attached Investor News and the Cash Flow Statement.
Material Changes
The filing text does not provide specific data regarding material changes in financial performance compared to the prior comparable period. Investors must refer to the attached Investor News for year-over-year comparisons.
Guidance, Outlook, and Risks
Management Commentary: Management states that the inclusion of non-GAAP measures (EBITDA and free cash flow) is intended to enhance the user's understanding of current financial performance and future prospects. These measures are also included to ensure consistency and comparability with prior periods where they were previously reported.
Regulatory Note: The filing emphasizes that non-GAAP measures should not be used as a substitute for or considered superior to GAAP financial measures.
Risks and Contingencies: No specific risks or contingencies are detailed in the cover letter text of this Form 6-K.
Investor Verification Checklist
- Review the attached Investor News (Exhibit 99.1) for specific Q1 2010 revenue, net income, and EBITDA figures.
- Verify the reconciliation of non-GAAP measures (EBITDA, free cash flow) to GAAP measures as presented in the exhibit.
- Compare Q1 2010 results against Q1 2009 data found in the exhibit to assess material changes.
- Confirm the Company's forward-looking guidance and outlook statements within the full news release.